Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factors.

Nozaki Y, Shiga T, Ri J, Itami T, Tomita D, Yamazawa H, Morimoto Y, Fukuda R, Tsuchimoto T, Morita S, Akazawa H, Murata K, Onishi A, Ebina K, Shirasugi I, Yamada H, Hashimoto M, Watanabe R, Wada Y, Takeuchi T, Amuro H, Tanaka A, Katayama M, Etani Y, Yamamoto W, Kinoshita K, Rai S.

Open source

DOI
10.1016/j.ard.2026.03.029
Published
2026-04-27
Container
Ann Rheum Dis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ard.2026.03.029,
  title = {Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factors.},
  author = {Nozaki Y and  Shiga T and  Ri J and  Itami T and  Tomita D and  Yamazawa H and  Morimoto Y and  Fukuda R and  Tsuchimoto T and  Morita S and  Akazawa H and  Murata K and  Onishi A and  Ebina K and  Shirasugi I and  Yamada H and  Hashimoto M and  Watanabe R and  Wada Y and  Takeuchi T and  Amuro H and  Tanaka A and  Katayama M and  Etani Y and  Yamamoto W and  Kinoshita K and  Rai S.},
  year = {2026},
  journal = {Ann Rheum Dis},
  doi = {10.1016/j.ard.2026.03.029},
  url = {https://doi.org/10.1016/j.ard.2026.03.029}
}

RIS

TY  - JOUR
TI  - Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factors.
AU  - Nozaki Y
AU  -  Shiga T
AU  -  Ri J
AU  -  Itami T
AU  -  Tomita D
AU  -  Yamazawa H
AU  -  Morimoto Y
AU  -  Fukuda R
AU  -  Tsuchimoto T
AU  -  Morita S
AU  -  Akazawa H
AU  -  Murata K
AU  -  Onishi A
AU  -  Ebina K
AU  -  Shirasugi I
AU  -  Yamada H
AU  -  Hashimoto M
AU  -  Watanabe R
AU  -  Wada Y
AU  -  Takeuchi T
AU  -  Amuro H
AU  -  Tanaka A
AU  -  Katayama M
AU  -  Etani Y
AU  -  Yamamoto W
AU  -  Kinoshita K
AU  -  Rai S.
PY  - 2026
JO  - Ann Rheum Dis
DO  - 10.1016/j.ard.2026.03.029
UR  - https://doi.org/10.1016/j.ard.2026.03.029
ER  - 

APA

Y, N., T, S., J, R., T, I., D, T., H, Y., Y, M., R, F., T, T., S, M., H, A., K, M., A, O., K, E., I, S., H, Y., M, H., R, W., Y, W., T, T., H, A., A, T., M, K., Y, E., W, Y., K, K., & S., R. (2026). Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factors.. Ann Rheum Dis. https://doi.org/10.1016/j.ard.2026.03.029

Source records